[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342087-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342087-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mrto4-acts-as-an-independent-prognostic-and-immunological-biomarker-and-is-correlated-with-tumor-microenvironment-in-hepatocellular-carcinoma","MRTO4 acts as an independent prognostic and immunological biomarker and is correlated with tumor microenvironment in hepatocellular carcinoma","","MRTO4 (mRNA turnover 4 homolog) is highly expressed in hepatocellular carcinoma (HCC) tissues, and its clinical and immunological significance is evaluated using TCGA, TCIA, and THPA resources. Stromal, immune, and ESTIMATE scores are quantified, while single-sample gene set enrichment and CIBERSORT estimate immune status and infiltration. MRTO4 overexpression is linked to poorer prognosis, higher tumor stage and grade, and elevated tumor microenvironment, TMB, and immune checkpoint gene expression. Drug-sensitivity analyses also indicate distinct IC50 responses. Results support MRTO4 as an independent prognostic immunological biomarker and potential therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mrto4-acts-as-an-independent-prognostic-and-immunological-biomarker-and-is-correlated-with-tumor-microenvironment-in-hepatocellular-carcinoma/342087/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mrto4-acts-as-an-independent-prognostic-and-immunological-biomarker-and-is-correlated-with-tumor-microenvironment-in-hepatocellular-carcinoma/342087.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What dataset sources and analytical packages were used to study MRTO4 in HCC?","Question",{"text":63,"@type":64},"The study uses TCGA, TCIA, and THPA for data and employs the ESTIMATE R package, single-sample GSEA, and CIBERSORT to assess immune status and infiltration.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MRTO4 expression relate to prognosis and clinicopathological features in HCC?",{"text":68,"@type":64},"MRTO4 overexpression is associated with poor prognosis and shows positive correlations with tumor stage and grade.",{"name":70,"@type":61,"acceptedAnswer":71},"How is MRTO4 linked to the tumor immune environment and immune checkpoint genes?",{"text":72,"@type":64},"Low-MRTO4 and high-MRTO4 groups differ significantly in immunophenoscore and tumor microenvironment scores, and MRTO4 expression positively correlates with tumor mutation burden and most immune checkpoint gene expressions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342087,1790195534,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Brazilian Journal of Medical and Biological Research (2024) 57: e13780, [https://doi.org/10.1590/1414-431X2024e13780](https://doi.org/10.1590/1414-431X2024e13780)  \nISSN 1414-431X Research Article  \n1/10  \nMRTO4 acts as an independent prognostic and immunological biomarker and is correlated with tumor microenvironment in hepatocellular carcinoma  \nBaobao Liang 1* 00 , Lan Li2* 00 , Chenyang He 1 00 , Meng Wang 1 00 , and Guochao Mao 1 00   \n1Department of Oncology, The Second Afﬁliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China 2Department of Breast Surgery, Shaanxi Provincial Cancer Hospital, Xi’an, Shaanxi, China  \nAbstract  \nLiver cancer is a malignant tumor found worldwide. mRNA turnover 4 homolog (MRTO4) is highly expressed in hepatocellular carcinoma (HCC) tissues, and we explored its relationship with HCC. All cancer data were downloaded from the Cancer Genome Atlas (TCGA), the Cancer Immune Atlas (TCIA), and the Human Protein Atlas (THPA) . Stromal scores, immune scores, and ESTIMATE scores were calculated by ‘‘ESTIMATE’’ R package. Single sample gene set enrichment analysis and CIBERSORT were used to evaluate the immune status and inﬁltration of cancer tissues. pRRophetic R package was used to predict the half-maximal inhibitory concentration (IC50) of different drugs in each sample. MRTO4 overexpression was associated with poor prognosis in HCC, and positively correlated with the stage and grade of HCC patients. The average immunophenoscore (IPS) of the low MRTO4 group was signiﬁcantly higher than that of the high MRTO4 group. Tumor microenvironment (TME) scores were signiﬁcantly higher in the low MRTO4 group than in the high MRTO4 group in HCC. MRTO4 expression was positively correlated with tumor mutation burden (TMB) and was positively correlated with most immune checkpoint gene expressions in HCC. Drug sensitivity analysis showed signiﬁcantly higher IC50 values for 5-ﬂuorouracil, gemcitabine, and sorafenib in patients with low MRTO4 expression than in those with high MRTO4 expression. MRTO4 acts as an independent prognostic and immunological biomarker and is correlated with clinical stage, tumor grade, and drug sensitivity in HCC. It may serve as a putative therapeutic target and potential biomarker for prognosis of HCC.  \nKey words: MRTO4; Clinicopathological features; Immune cell inﬁltration; Immunophenoscore; Tumor microenvironment; Hepatocellular carcinoma  \nIntroduction  \nLiver cancer is the seventh most common malignant tumor globally, with about 841,000 new cases and 7.82 million deaths annually worldwide. Hepatocellular carcinoma (HCC) comprises nearly 90% of all cases of primary liver cancer (1) . China is the leading country for liver cancer, with the fourth and second highest incidence and mortality rates. The causes of this poor prognosis include severe underlying liver disease, delayed diagnosis, and lack of effective treatment. Furthermore, mortality from HCC is increasing faster than any other cancer. Despite some encouraging progress, treatment options for patients with advanced HCC remain very limited. This unsatisfactory clinical management of HCC patients is largely attributed to the lack of ideal prognostic markers and therapeutic targets.  \nRibosome biogenesis, as a major consumer of cellular energy, plays a key role in cellular adaptation to environmental changes and has a powerful impact on cellular metabolism and cell cycle regulation (2–4) . Its regulation is associated with post-translational modiﬁcations of TAF (trans-acting factor) . As a member of the TAF family, MRTO4 is involved in eukaryotic ribosome biogenesis and is closely associated with tumors (5,6) . It has been reported to be signiﬁcantly overexpressed in ovarian cancer cells with aggressive biological behavior and in invasive gastric cancer (7,8) . In addition, MRTO4 wasidentiﬁed as one of the hub susceptibility genes for COVID-19 in lung adenocarcinoma (9) and has been shown to display signiﬁcant mRNA alt","cbCaioyqGGWtwPut","https://ap.wps.com/l/cbCaioyqGGWtwPut","pdf",1927169,"English","# Abstract\n# Introduction\n# Material and Methods\n## Data acquisition and expression analysis\n## Comparison of the characteristics between the high and low MRTO4 expression groups","[{\"question\":\"What dataset sources and analytical packages were used to study MRTO4 in HCC?\",\"answer\":\"The study uses TCGA, TCIA, and THPA for data and employs the ESTIMATE R package, single-sample GSEA, and CIBERSORT to assess immune status and infiltration.\"},{\"question\":\"How does MRTO4 expression relate to prognosis and clinicopathological features in HCC?\",\"answer\":\"MRTO4 overexpression is associated with poor prognosis and shows positive correlations with tumor stage and grade.\"},{\"question\":\"How is MRTO4 linked to the tumor immune environment and immune checkpoint genes?\",\"answer\":\"Low-MRTO4 and high-MRTO4 groups differ significantly in immunophenoscore and tumor microenvironment scores, and MRTO4 expression positively correlates with tumor mutation burden and most immune checkpoint gene expressions.\"}]","MRTO4 acts as an independent prognostic and immunological biomarker and is correlated with tumor microenvironment in hepatocellular carcinoma | PDF",1790045110,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/213cb57f0765a11178dd50743acd77b6.webp",983,1269,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84c34d122aabc828847181cf05da6a44.webp",982,1268,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2074f31c6184760771815ba892c4165e.webp",981,1266,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fac7393d323d4a4c0770b6ec5d128fa5.webp",980,1265]